Advertisement

Kahn Swick & Foti, LLC Company Profile

18:02 EDT 24th May 2013 | BioPortfolio

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action litigation with offices in New York and Louisiana. KSF's lawyers have significant experience litigating complex securities class actions nationwide on behalf of both institutional and individual shareholders. Recent cases include In re Virgin Mobile USA IPO Litigation, 2:07-cv-05619-SDW-MCA (D. N.J.), Co-Lead Counsel, $19.5 Million Settlement Preliminarily Approved; In re BigBand Networks, Inc Securities Litigation, 3:07-CV-05101-SBA (C.D. Cal.), Co-Lead Counsel, $11 million settlement; In re U.S. Auto Parts Networks, Inc. Securities Litigation, 2:07-cv-02030-GW-JC (C.D. Cal.),Lead Counsel, $10 million settlement. KSF is also federally court-appointed Co-Lead Counsel in THE shareholder derivative cases against AIG and Bank of America (Merrill Lynch merger) emanating from their recent multi-billion dollar economic declines.


News Articles [ 49 Associated News Articles listed on BioPortfolio]

VENTRUS BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ventrus Biosciences, Inc. - VTUS

NEW ORLEANS, LA -- (Marketwired) -- 05/09/13 -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

INVESTOR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Large Financial Interests of Important Deadline in Lawsuit Against Accretive Health, Inc. - AH

NEW ORLEANS, June 22, 2012 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...

IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Action Lawsuit Against Impax Laboratories, Inc.

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $150,000 that they ha...

AFFYMAX 96 HOUR SHAREHOLDER ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Large Financial Interests of Important Deadline in Lawsuit Against Affymax, Inc.

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until April 29, 2013 to fi...

INVESTOR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against Zillow Inc. - Z

NEW ORLEANS, Jan. 25, 2013 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...

INVESTOR ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC, Remind Investors With Large Financial Interests of Lead Plaintiff Deadline in Class Action Lawsuit Against Big Lots, Inc. -- BIG

NEW ORLEANS, July 15, 2012 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have unti...

INVESTOR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against Nokia Corporation -- NOK

NEW ORLEANS, June 28, 2012 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...

INVESTOR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against Align Technology, Inc. -- ALGN

NEW ORLEANS, Jan. 25, 2013 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only...

Drugs and Medications [ 2 Associated Drugs and Medications listed on BioPortfolio]

Dipentum [Alaven Pharmaceutical LLC]

Dipentum (olsalazine sodium capsules)

Dipentum (olsalazine sodium capsules) [UCB, Inc.]

DIPENTUM (olsalazine sodium capsules)

PubMed Articles [ 7 Associated PubMed Articles listed on BioPortfolio]

Indolent CD8+ lymphoid proliferation of the ear: report of two cases and review of the literature.

Indolent CD8+ lymphoid proliferation of the ear is a recently described cutaneous lymphoid proliferation that clinically presents with slow growing lesion(s) on the ear(s). In cases reported to date,...

Abnormal Neural Sensitivity to Monetary Gains Versus Losses Among Adolescents at Risk for Depression.

Major depressive disorder aggregates within families, although the mechanisms of transfer across generations are not well understood. In light of converging biological and behavioral evidence that dep...

Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.

The essential micronutrient selenium is found in proteins as selenocysteine (Sec), the only genetically encoded amino acid whose biosynthesis occurs on its cognate tRNA in humans. In the final step of...

Integration of SNP genotyping confidence scores in IBD inference.

High-throughput single nucleotide polymorphism (SNP) arrays have become the standard platform for linkage and association analyses. The high SNP density of these platforms allows high-resolution ident...

Do females preferentially associate with males given a better start in life?

A poor start in life owing to a restricted diet can have readily detectable detrimental consequences for many adult life-history traits. However, some costs such as smaller adult body size are potenti...

Clinical Trials [ 1 Associated Clinical Trials listed on BioPortfolio]

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

This study intends to compare novel antipsychotics ziprasidone and olanzapine, to confirm the findings of an open study -where stable patients receiving olanzapine switched to ziprasidone-...

Companies [ 2 Associated Companies listed on BioPortfolio]

Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities class action litigation with offices in New York and Lo...

Attorney Robert A. Kahn

More Information about "Kahn Swick & Foti, LLC" on BioPortfolio

We have published hundreds of Kahn Swick & Foti, LLC news stories on BioPortfolio along with dozens of Kahn Swick & Foti, LLC Clinical Trials and PubMed Articles about Kahn Swick & Foti, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kahn Swick & Foti, LLC Companies in our database. You can also find out about relevant Kahn Swick & Foti, LLC Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement